OncoSec Medical Inc (ONCSQ)

[philospher42]

There are a few scenarios that get us to $20 this year. However, most of them are unlikely. The one real possibility is very good P2B results. Imagine the scenario at about the 6 month mark preliminary P2B results are outstanding. If the combo caused 90%+ systemic response rates the FDA would likely stop the trial given the known safety profile. The stock would rise to 20+ overnight on hype alone. I would not count on this scenario as real world results will most likely be less than the mouse models. The far fetched schemes to get to $20 would have odds of < 1%. This one is much better though as there is a very sound scientific rational. If forced, I would place the odds at about 10%, which is actually outstanding.